Summary
Subcommittee spoke positively about FDA's Draft Action Plan
Subcommittee generally agreed with FDA's approach and planned research activities
Subcommittee provided recommendations on certain aspects of the plan
- Toxicology
- Epidemiology
- Exposure assessment
- Risk assessment
- Risk communication
Department of Health and Human Services